A new unusually threatening virus that leads to colds and other respiratory infections has caused 10 deaths in the last 18 months according to a new report released by the U.S. Centers for Disease Control and Prevention on Thursday.

Adenoviruses cause respiratory infections that are not considered a real threat to people. Usually this virus does not lead to death.

This new virus has caused more than 140 illnesses in New York, Oregon, Washington and Texas.

"Whether you're a healthy young adult, an infant, or an elderly person, this virus can cause severe respiratory disease at any age. What brought this to our attention is that it can cause severe respiratory diseases in otherwise healthy adults," said John Su, an investigator of infectious diseases with the CDC and a contributor to the report.

More than 50 distinct types of adenoviruses are linked to human illnesses and they can be the cause of common cold. They also can lead to pneumonia and bronchitis.

Other adenoviruses have been related to gastroenteritis, conjunctivitis and cystitis.

The first case of this mutated virus was discovered in an infant girl in New York City who died lat year, according to the CDC report. The child, healthy after birth, became dehydrated and lost appetite. She died 12 days later.

Dr. John Su said that she was infected with a form of adenovirus, called Ad14, but slightly modified.

At the beginning of 2007, more than a hundred trainees at Lackland Air Force Base in San Antonio became ill with respiratory infections. At least 106 of them had the mutated form of Ad14, five of them ending up in an intensive care unit.

Another 31 cases were registered at a Portland-area hospital from Oregon in April. Seven of them died from severe pneumonia. The Washington state officials reported four hospitalized patients in May. One of them, suffering from AIDS, died.

The first case of Ad14 infection was identified in 1955 among military recruits in the Netherlands and 14 years later caused severe damages between military recruits stationed in Europe. The infection has been rarely detected since then.

A Barr Pharmaceutical vaccine for the military is currently being tested and is expected to be licensed in 2009.

The health specialists from the CDC said that a vaccination against the mutant Ad14 is really needed.

"If it persists, then we'd consider if the vaccine needs to be modified further," said Col. Art Brown, of the U.S. Army Medical Materiel Development Activity, according to Associated Press.